tailieunhanh - Báo cáo y học: "Procalcitonin in liver transplant patients - yet another stone turned"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: Procalcitonin in liver transplant patients - yet another stone turned. | Available online http content 12 1 108 Commentary Procalcitonin in liver transplant patients - yet another stone turned Jens-Ulrik Jensen1 2 and Jens D Lundgren2 3 From the Procalcitonin And Survival Study PASS 1 Department of Clinical Microbiology 445 Copenhagen University Hospital Kettegaard Allé 30 DK-2650 Hvidovre Denmark 2Copenhagen HIV Programme University of Copenhagen Faculty of Health Sciences The Panum Institute Building Blegdamsvej 3B DK-2200 Copenhagen N Denmark 3Centre for Viral Diseases KMA Rigshospitalet Blegdamsvej 9 DK-2100 Copenhagen 0 Denmark Corresponding author Jens-Ulrik Jensen koordinator@ Published 22 January 2008 This article is online at http content 12 1 108 2008 BioMed Central Ltd Critical Care 2008 12 108 doi cc6221 See related research by Zazula et al. http content 11 6 R131 Abstract Liver transplantation has been reported to initiate increases in procalcitonin levels in the absence of bacterial infection. The results of a study investigating the course of procalcitonin levels over several days after liver transplantation in noninfected patients were recently reported in Critical Care. This study shows that procalcitonin levels increase only transiently immediately after surgery and thereafter they rapidly decrease. This new information gives us hope that procalcitonin can be used as a marker of bacterial infection in these patients. Further studies of patients undergoing liver transplantation with and without bacterial infection are needed. Recently in Critical Care Zazula and colleagues 1 reported a study in which they conducted daily measurement of the biomarker procalcitonin in patients undergoing liver transplantation and resection. The findings provide novel clinical and molecular information on this biomarker. In patients with severe organ impairment and in critically ill patients bacterial infection is both common and among the most feared complications because .

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN
crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.